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Infection of 13 month-old CsH mice with EMC virus or inoculation with the interferon inducer 
poly(I)poly(C) results in elevated levels of the enzyme 2’,5’ oligo(A) synthetase only in animals with 
spontaneous tumors (breast cancer or hepatomas). High enzymatic activities are detected in homogenates 
from liver, spleen, plasma and neoplastic cells of the animals with breast carcinomas and only in the 
neoplastic liver cells of the animals with hepatomas. 
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1. INTRODUCTION 
Recent studies on the mechanism of action of 
interferon have revealed the induction, in inter- 
feron-treated cells, of a number of proteins which 
are generally accepted as the enzymes responsible 
for the multiple effects of interferon [ 1,2]. One of 
these enzymes is the 2’,5’ oligo(A) synthetase 
catalysing the synthesis of an. oligonucleotide, 
pppA(2’ p5’A)n [3]. This oligonucleotide, with its 
unusual 2’-5’ phosphodiester bonds, activates a 
latent endoribonuclease and therefore enhances 
mRNA degradation. There are a few reports which 
show that the same enzymatic system might operate 
in experimental mice treated with interferon or 
interferon inducers since one of the enzymes in- 
volved in the system, i.e. the 2’,5’ oligo(A) synthe- 
tase is induced in different organs of these animals 
[4-61. 
tumors to a lesser extent (by the age of 10 months 
50% of the females and 60% of the males produce 
breast cancer and hepatomas, respectively). 
We estimate here the levels of the 2’S’ oligo(A) 
synthetase in various tissues of healthy and tumor- 
bearing C3H mice. 
2. MATERIALS AND METHODS 
2.1. Interferon inducers 
Encephalomyocarditis (EMC) virus was grown in 
BHK/Cis cells. Its titration was carried out using 
a plaque assay in the same type of cells. Poly(I)- 
poly(C) was purchased from Serva, Heidelberg. 
2.2. Animals 
The CsH mouse is a laboratory strain which is 
known to produce spontaneous tumors. The per- 
centage of these animals producing tumors varies 
according to the breeding status and environmen- 
tal stress [7]. It has been reported that by the age 
of 7.2 months, 99% of the female mice produce 
breast cancer and by 14 months 85% of the males 
produce hepatomas [S]. The inbred C3H mice kept 
in our Institute since 1961 produce spontaneous 
Thirteen-month-old CsH mice were used for this 
investigation. Essentially 4 groups of animals were 
used: female healthy or with breast tumor and 
male healthy or with hepatomas. EMC virus 
(5 x lo6 p.f.u./mouse) was administered intraperi- 
toneally and poly(I)poly(C) (10 mg/kg body wt) 
was administered intravenously. 
2.3. Plasma preparation and tissue extracts 
After ether anesthesia, mice were bled from 
the auxillary vessels, the blood was collected in 
Published by Elsevier Science Publishers B. V. 
00145793/83/$3.00  1983 Federation of European Biochemical Societies 161 
Volume 164, number 1 FEBS LETTERS November 1983 
polystyrene tubes containing 50~1 sodium citrate 
(3 mg/ml), and left for 15-30 min at 4°C. Plasma 
was collected after centrifugation (2000 x g, 15 min) 
and stored at -80°C. 
Tissues frozen in liquid nitrogen were homo- 
genized mechanically (Dounce homogenizer) in 
buffer containing 1OmM KCI, 1.5 mM MgClz, 
0.5 mM DDT and 20 mM Hepes (pH 7.4) [4]. The 
cell homogenate was then centrifuged at 10000 x g 
for 10 min and the supernatant representing the SO 
cell fraction was stored in liquid nitrogen. 
2.4. Assay of2’,5’ &go(A) synthetase 
The activity of 2’,5’ oligo(A) synthetase is esti- 
mated by following the conversion of 3H-labelled 
ATP (Amersham) to adenosine oligomers as in [9]. 
Incubations were for 24 h at 30°C followed by 
precipitation of the mixture with 6~01s acetone. 
The proportion of ATP which is polymerized is 
calculated by separating the synthesized oligomers 
from monomers with small DEAE-cellulose col- 
umns [4]. The activity of the 2’,5’ oligo(A) synthe- 
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(3H-labelled ATP) which is converted to a mixture 
of oligonucleotides. 
3. RESULTS 
Apparently healthy animals or animals with 
spontaneous tumors (CrH females with breast 
cancer or males with hepatomas) were injected 
intraperitoneally with EMC virus (5 x lo6 p.f.u./ 
mouse). At the times after injection shown in fig. 1, 
the animals were killed and the levels of 2’,5’ 
oligo(A) synthetase were estimated in various 
tissues of the neoplastic or healthy animals. 
The data presented in fig.l,2 show that: 
(i) In healthy animals the activity of the 2’,5’ 
oligo(A) synthetase is very low at the time of 
virus infection (points at zero time of the 
graphs) and virus infected animals (fig.la-c, 
fig.2a-c). OnIy liver cells from either healthy 
females or males show low, but detectable 
levels, of synthetase after inoculation with 
EMC virus (fig. la,2a). 
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Fig.1. 2’,5’ Oligo(A) synthetase activity in C3H mice at different times after EMC virus infection. Top row, healthy 
animals; bottom row, animals with breast cancer, Homogenates prepared from: (a,d), spleen (b,e), plasma (c,f) and 
neoplastic tissue (g). 
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Fig.%. 2’S’ Oligo(A) synthetase activity in CsH mice at 
different times after EMC virus infection. Top row, 
healthy animals; bottom row, animals with hepatomas. 
Homogenates prepared from: liver (a,d), spleen (b,e) 
and plasma (c,f). 
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Fig.3. 2’,5’ Oligo(A) synthetase activity in CrH mice at 
different times after inoculation of the mice with 
poly(I)poly(C) (10mglkg boty wt). Top row, healthy 
animals; bottom row, animals with breast cancer. 
Homogenates prepared from: liver (a,d), spleen (b,e), 
plasma (c,f) and neoplastic tissue (g). 
(ii) 
(iii) 
2’,5’ Ohgo synthetase in tumor-bearing 
animals (breast cancer or hepatomas) is de- 
tected at elevated levels only after infection 
with the virus (fig.ld-g, fig.2d-f). 
The increased activity of the enzyme after in- 
fection is detected in the homogenates pre- 
pared from liver, spleen, plasma, as well as 
the tumor cells of the breast cancer-bearing 
animals, whereas the same enzymatic activity 
is observed only in the liver cells (neoplastic 
cells) of animals with hepatomas. 
Similar results were obtained when C3H mice 
were inoculated with poly(I)poly(C), a good inter- 
feron inducer [lo]. Poly(I)poly(C) results in the in- 
duction of synthetase only in C3H mice which 
bear spontaneous tumors (fig.3,4). Inoculation of 
healthy animals with poly(I)poly(C~ has no effect 
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Fig.4. 2’,5’ Oligo(A) synthetase activity in C3H mice at 
different times after inoculation of the mice with 
poly(I)poly(C) (lOmg/kg body wt). Top row, healthy 
animals; bottom row, animals with hepatomas. Homo- 
genates prepared from: liver (a,d), spleen (b,e) and 
plasma (c,f). 
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on the levels of the synthetase xcept that of liver 
where again the enzyme is induced but in low levels 
(fig.4a). 
4. DISCUSSION 
The aim of these experiments is to show the pre- 
sence of 2’3 oligo(A) synthetase in experimental 
animals, its distribution in various animal organs, 
its induction with virus or dsRNA and finally the 
demonstration of the effect, if any, of the tumor 
on the synthetase system. 
With the synthetase assay used here we were un- 
able to detect significant levels of the enzyme in the 
organs tested in control animals (virus non-infected 
of dsRNA non-inoculated). An exception to this 
finding are the levels of the enzyme in liver cells. 
Homogenates from livers of healthy females or 
males show detectable levels of 2’3’ oligo(A) syn- 
thetase after virus of poly(I)poly(C) treatment. 
Considering that this assay detects enzyme quanti- 
ties which convert 1% of the ATP present in the 
assay mixture [4], we conclude that except for liver 
homogenates, the level of the 2’3’ oligo(A) synthe- 
tase in the various tissues of ‘our CsH mice’ is very 
low and in this respect the CjH mice used in this 
work are different from those used by others [6]. 
The fact that the results obtained with either 
EMC virus or poly(I)poly(C) were similar shows 
that synthetase induction is probably a conse- 
quence of the interferon synthesized by the animals 
in response to virus infection or dsRNA inocula- 
tion. This finding is in agreement with all the pub- 
lished work [4-61. What is puzzling is our finding 
that the induction of the synthetase with interferon 
inducers is possible only in animals with spon- 
taneous tumors. It appears that the presence of the 
tumor plays an essential role in the induction of 
this enzyme. This is in contrast to previously pub- 
lished works [4-61 in which the induction of high 
levels of 2-5A synthetase has been shown in 
different organs of normal mice injected with 
poly(I).poly(C) or infected with EMC virus. The 
controversy between these and our results requires 
further studies in order to be clarified. It is generally 
accepted that the induction of the synthesis of 
various proteins in the cell by interferon is the re- 
sult of a derepressive procedure of certain genes 
which in the normal cell are under tight negative 
control [ll] (i.e. these genes are not expressed in 
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the normal cell). It seems, for some unknown 
reason, that the presence of the tumor in the 
animal might have an auxiliary effect on this 
‘depressive’ function of interferon. However, the 
more effective induction of the synthetase in the 
tissues of tumor bearing animals could be simply 
the result of a greater amount of interferon synthe- 
sized in these animals. Recent preliminary experi- 
ments on synthetase induction with interferon in 
both healthy and neoplastic animals show that the 
production of interferon cannot alone account for 
the differences observed on synthetase induction 
since we find that the same amount of exogenous 
interferon induces higher levels of synthetase in the 
animals with tumors. Both possibilities described 
above, i.e. (a) the function of interferon (derepres- 
sion) is more effective in animals with tumors and 
(b) interferon inducers produce larger amounts of 
interferon in neoplastic mice, support the observa- 
tions we report. These possibilities will be further 
clarified when the measurement of circulating 
interferon in all the experimental mice becomes 
possible. The fact that the same phenomenon is 
observed with totally different tumors (breast 
cancer and hepatomas) leads to the conclusion that 
this might be a general situation which accom- 
panies neoplasia. It would be of interest to deter- 
mine whether the induction of 
thetase is also found in animals 
induced tumors. 
2’,5’ oligo(A) syn- 
bearing chemically 
ACKNOWLEDGEMENTS 
This work was supported by a grant from 
the Hellenic Cancer Society. We thank MS 
A. Efkarpidou-Georgiadou, E. Lazaridou-Vouka 
and M. Papadopoulou for excellent echnical assis- 
tance. 
REFERENCES 
[I] Zilberstein, A., Kimchi, A., Schmidt, A. and 
Revel, M. (1978) Proc. Natl. Acad. Sci. USA 75, 
4734-4738. 
[2] Schmidt, A., Chernajovsky, Y., Shulman, L., 
Federman, H., Berissi, H. and Revel, M. (1979) 
Proc. Natl. Acad. Sci. USA 76, 4788-4792. 
[3] Stark, R.G., Dower, J.W., Schimke, T.R., Brown, 
E.R. and Kerr, M.J. (1979) Nature 278, 471-473. 
[4] Krishnan, J. and Baglioni, C. (1980) Nature 285, 
485-488. 
Volume 164, number 1 FEBS LETTERS November 1983 
[5] Hovanessian, A.G. and Riviere, Y. (1980) Ann. 
Virol (Inst. Pasteur) 131E, 501-516. 
[6] Hovanessian, A.G., Riviere, Y., Robert, N., Svab, 
J., Chamaret, S., Guillon, J.C. and Montagnier, L. 
(1981) Ann. Virol. (Inst. Pasteur) 132E, 175-188. 
[7] Riley, V. (1975) Science 189, 465. 
[8] Heston, W.E. and Vlahakis, G. (1971) Int. J. 
Cancer 7, 141. 
[9] Koliais, S.I. and Kortsaris, A. (1982) J. Gen. Virol. 
58, 191-193. 
(lo] Burke, D.C. (1977) Sci. Am. 236, 42-50. 
[l l] Gupta, S.L., Rubin, B.Y. and Holmes, S.L. (1979) 
Proc. Natl. Acad. Sci. USA 76, 4817-4821. 
165 
